291 related articles for article (PubMed ID: 23100049)
1. Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.
Harada R; Okamura N; Furumoto S; Tago T; Maruyama M; Higuchi M; Yoshikawa T; Arai H; Iwata R; Kudo Y; Yanai K
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):125-32. PubMed ID: 23100049
[TBL] [Abstract][Full Text] [Related]
2. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
[TBL] [Abstract][Full Text] [Related]
3. Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.
Cai L; Qu B; Hurtle BT; Dadiboyena S; Diaz-Arrastia R; Pike VW
ACS Chem Neurosci; 2016 Jul; 7(7):897-911. PubMed ID: 27171905
[TBL] [Abstract][Full Text] [Related]
4. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
Leinonen V; Rauramaa T; Johansson J; Bottelbergs A; Tesseur I; van der Ark P; Pemberton D; Koivisto AM; Jääskeläinen JE; Hiltunen M; Herukka SK; Blennow K; Zetterberg H; Jokinen P; Rokka J; Helin S; Haaparanta-Solin M; Solin O; Okamura N; Kolb HC; Rinne JO
J Alzheimers Dis; 2018; 64(1):171-179. PubMed ID: 29865068
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation of [(18)F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer.
Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
Mol Imaging Biol; 2016 Apr; 18(2):258-66. PubMed ID: 26194011
[TBL] [Abstract][Full Text] [Related]
6. Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease.
Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
J Nucl Med; 2016 Apr; 57(4):608-14. PubMed ID: 26697966
[TBL] [Abstract][Full Text] [Related]
7. Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.
Okamura N; Suemoto T; Furumoto S; Suzuki M; Shimadzu H; Akatsu H; Yamamoto T; Fujiwara H; Nemoto M; Maruyama M; Arai H; Yanai K; Sawada T; Kudo Y
J Neurosci; 2005 Nov; 25(47):10857-62. PubMed ID: 16306398
[TBL] [Abstract][Full Text] [Related]
8. [(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease.
Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Tago T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1052-61. PubMed ID: 25792456
[TBL] [Abstract][Full Text] [Related]
9. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
10. [
Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
[TBL] [Abstract][Full Text] [Related]
11. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Andersen P; Jonasson M; Eriksson J; Lubberink M; Almkvist O; Wall A; Antoni G; Nordberg A
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1686-99. PubMed ID: 26996778
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Comparison of Tau Radioligands
Betthauser TJ; Lao PJ; Murali D; Barnhart TE; Furumoto S; Okamura N; Stone CK; Johnson SC; Christian BT
J Nucl Med; 2017 Jun; 58(6):996-1002. PubMed ID: 27856627
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
Vallabhajosula S
Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer.
Fodero-Tavoletti MT; Brockschnieder D; Villemagne VL; Martin L; Connor AR; Thiele A; Berndt M; McLean CA; Krause S; Rowe CC; Masters CL; Dinkelborg L; Dyrks T; Cappai R
Nucl Med Biol; 2012 Oct; 39(7):1042-8. PubMed ID: 22503458
[TBL] [Abstract][Full Text] [Related]
15. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.
Shin J; Lee SY; Kim SH; Kim YB; Cho SJ
Neuroimage; 2008 Nov; 43(2):236-44. PubMed ID: 18694837
[TBL] [Abstract][Full Text] [Related]
16. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an APP/tau rat model of Alzheimer's disease by positron emission tomography and immunofluorescent labeling.
Filip T; Mairinger S; Neddens J; Sauberer M; Flunkert S; Stanek J; Wanek T; Okamura N; Langer O; Hutter-Paier B; Kuntner C
Alzheimers Res Ther; 2021 Oct; 13(1):175. PubMed ID: 34656177
[TBL] [Abstract][Full Text] [Related]
18. Discovery and preclinical characterization of [
Kroth H; Oden F; Molette J; Schieferstein H; Capotosti F; Mueller A; Berndt M; Schmitt-Willich H; Darmency V; Gabellieri E; Boudou C; Juergens T; Varisco Y; Vokali E; Hickman DT; Tamagnan G; Pfeifer A; Dinkelborg L; Muhs A; Stephens A
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2178-2189. PubMed ID: 31264169
[TBL] [Abstract][Full Text] [Related]
19. Tau imaging with [
Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
[TBL] [Abstract][Full Text] [Related]
20. A Novel Near-Infrared Fluorescence Probe THK-565 Enables In Vivo Detection of Amyloid Deposits in Alzheimer's Disease Mouse Model.
Naganuma F; Murata D; Inoue M; Maehori Y; Harada R; Furumoto S; Kudo Y; Nakamura T; Okamura N
Mol Imaging Biol; 2023 Dec; 25(6):1115-1124. PubMed ID: 37580462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
